The PennZone

  • Home
  • Non-profit
  • Books
  • Health
  • Marketing
  • Entertainment
  • Business
  • Sports
  • Legal

Good news! The COVID-19 vaccine is coming to Whittier Health Network in Massachusetts
The PennZone/10102000

Trending...
  • WebDrafter Welcomes Dreamwork Exteriors as a New Marketing Client
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Communities In Schools of Eastern Pennsylvania Honors United Way and Local Leaders
Dr Paul Liguori receiving vaccine Philip Arcidi, Treasurer receiving vaccine Whittier Rehabilitation Hospital
The vaccine will be distributed at the Skilled Nursing Facilities, through a partnership with CVS, on a schedule beginning December 29th, and at our Transitional Care Units starting January 4th.

HAVERHILL, Mass. - PennZone -- Here's what you need to know.

At Whittier Health Network, we are dedicated to the well-being of our patients, residents, and staff, and we care for them just like family. That's why we are making sure the COVID-19 vaccine will be available at all of our facilities now that it is approved by the FDA and is currently being distributed.

We will hold a "vaccine clinic" throughout the Whittier Health Network beginning the last week of December. We urge our employees to sign up—for their safety and for the protection of their families and those they care for here at Whittier.

Our Medical staff will be taking the vaccine including our Medical Directors, Dr. Paul Liguori, MD, MRM at Whittier Rehabilitation Hospital Bradford and Dr. John V. Turchetta at Whittier Rehabilitation Hospital Westborough. Senior management at Whittier will also receive the vaccine to show leadership to staff and to show that the vaccine is safe.

More on The PennZone
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
  • Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
  • Inaugural OC Tech Week Draws 3,000 From 12 Countries, Sends Finalist to $1M Startup World Cup
  • Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England

The vaccine will be distributed at the Skilled Nursing Facilities, through a partnership with CVS, on a schedule beginning December 29th, and at our Transitional Care Units starting January 4th. Our excellent healthcare staff, patients, and residents take priority and will receive the vaccines first.

A 90% or more adoption rate will significantly reduce outbreaks within each facility. The goal is 100%. It will take many resources to accomplish, but we're up to the task of keeping our family safe.

We also plan to implement CVS's VSafe app, a smartphone-based post-vaccination application that will allow those who have been vaccinated to sign up for monitoring post-vaccine statuses going forward. VSafe incorporates text messages and web surveys and relays information back to the CDC about how those who have been vaccinated are doing post-vaccine.

Visit our blog, where Dr. Paul Liguori at Whittier Rehabilitation Hospital Bradford, explains the vaccine process and how it works within your body: https://hubs.ly/H0CM8cN0.

For more information from the Centers for Disease Control, visit http://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html.

We look forward to the vaccine helping to protect the well-being of our employees, residents and patients.

Contact
Kathy Soderberg - Chief Compliance Officer
***@whittierhealth.com


Source: Whittier Health Network
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Hunter's Garage Teams Up With The Small Batch for a Free Thanksgiving Meal
  • TradeJARnal Launches Innovative Trading Journal to Help Stock and Options Traders Build Discipline and Smarter Trading Habits
  • Pursant Founder Mark Herbick Joins STS Capital Partners as CEO
  • Tampa Holiday Sessions: Captured by Mallary Opens 2026 Christmas Minis With Two New Sets
  • Tampa Web Design Launches New Website for Entrepreneur and Capital Markets Advisor Martin Sumichrast
  • Miami Dade College and World Affairs Council of Miami announce Navarro-Cabrera scholarship
  • Bridging Canvas and Cosmos: How Bioengineer Farin DeBose Captured the Essence of "True Science"
  • RPP to host first Professional Padel Week in Miami and announce the 2026 USA Awards winners
  • UK Financial Ltd. Announces Maya Preferred PRA as First Fully Verified Asset on MAYA CHAIN; Chainlink Proof of Reserve Integration Planned for Network
  • ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
  • NAO Releases Shopping Intelligence to Streamline Your Quest for Value
  • International Misophonia Foundation Launches Sensory Accessible Technology Initiative to Address Overlooked Digital Accessibility Barriers
  • The Robert Travers Team of Long & Foster Marks 300+ Homes Sold, Expands Seller Representation
  • CLINIMED Becomes First Liposuction Cannula Maker to Offer 3D and AR Models of Its Cannula Range
  • RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
  • Heritage at Manalapan Announces New 3.875% First-Year Mortgage Rate Buydown (7.11 APR)
  • Conservative Latinos for PA PAC Endorses Stacy Garrity for Governor: "Pennsylvania's Latino Families Need a Leader Who Delivers"
  • AthleteMerch.com Surpasses 100,000 Custom Items Delivered to Fans Nationwide
  • MoMojo Records Signs Gary Nicholson
  • Steve Weclew is Appointed by STS Capital Partners as Managing Director

Popular on PennZone

  • SMACK Fighting Championships Announces Influencer Fight Night at Harrah's Philadelphia - 210
  • ASSIST Software Wins Volkswagen Challenge for Automated Quality Inspection - 103
  • New Children's Picture Book "Tippy Tay" Explores the Dangers of Peer Pressure and the Importance of - 101
  • New Children's Picture Book "Adam's Apple" Celebrates Childhood Curiosity and the Funny Misundersta
  • RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover
  • LS2 Partners with Angels Of Dirt's "Next Chapter Racer" Series Celebrating Women and Girls in Motorsports
  • Free Senior Housing Webinar Helps Families Plan for Aging Before a Crisis Forces Difficult Decisions
  • What Mold Remediation Costs in Gettysburg, PA: 2026 Price Ranges by Job Type
  • Pittsburgh Digital Marketing Agency Moves to Babcock Boulevard in the North Hills
  • Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources

Similar on PennZone

  • TrueNorth Wellness Services Expands Rural Behavioral Health Care in Fulton County with Technology
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Ten Ten Ten Announces Maximizing Quality Performance, a Value-Based Care Implementation Guide
  • CLINIMED Becomes First Liposuction Cannula Maker to Offer 3D and AR Models of Its Cannula Range
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Best Black Friday 2026 Deals on Lightweight Foldable Electric Wheelchairs – Save Up to 60%
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
  • Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Win Gold in Raleigh's Best Awards for Second Consecutive Year
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us